$1.93
-3.47-64.26%
Last update: Nov 10, 7:59 PM
Basel Medical Group Ltd
BMGLNASDAQ
Basel Medical fell 69.2% from $17.52 to $5.40, behind the S&P 500's +9.8%. Its worst day was Jun 4 (−26.1%), and its low came Oct 1 at $3.02.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-6.07 was reported on $8.9M revenue.
+1.8% · S&P 500 −0.8%
Basel Medical shares rose 30.9%, while the S&P 500 fell 1.1%.
+30.9% · S&P 500 −1.1%
Story events cover the past 12 months · Times ET
Basel Medical shares rose 25.9%, while the S&P 500 fell 1.4%.
+25.9% · S&P 500 −1.4%
Basel Medical shares fell 26.1%, while the S&P 500 rose 0.4%.
−26.1%, the year's worst day · S&P 500 +0.4%
EPS of $0.01 was reported on $6.4M revenue.
+2.4% · S&P 500 −0.7%
Basel Medical shares rose 32.2%, while the S&P 500 rose 0.4%.
+32.2% · S&P 500 +0.4%
Basel Medical shares rose 30.7%, while the S&P 500 rose 0.0%.
+30.7% · S&P 500 0.0%
Basel Medical shares rose 54.7%, while the S&P 500 fell 0.4%.
+54.7%, the year's best day, on 32M shares, the year's heaviest volume · S&P 500 −0.4%
Basel Medical closed at its lowest level of the year, 82.8% below where the year started.
−3.2% · S&P 500 +0.2%
Where it ended: a close of $5.40 on Nov 9, 2026.
Nothing in the past 12 months.
All BMGL analyst actionsNothing in the past 12 months.
All BMGL dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BMGL and SPY from Benzinga historical bars. Not investment advice.
